Dow Down 0.32% Nasdaq Down 0.62%

More On GEN.CO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Genmab A/S (GEN.CO)

-Copenhagen
963.00 Down 8.00(0.82%) Apr 29
Prev Close:963.00
Open:967.00
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:958.50 - 970.00
52wk Range:501.00 - 993.00
Volume:1,309
Avg Vol (3m):477,317
Market Cap:57.47B
P/E (ttm):76.67
EPS (ttm):12.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in DKK.

Headlines

» More Headlines for GEN.CO

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):50.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-11) :N/A
Quarterly EPS Est (Sep-11) :N/A
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer in Denmark and internationally. The company markets Arzerra, a human monoclonal antibody for the treatment of chronic lymphocytic leukemia (CCL) worldw... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback